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Abstract
This review considers the molecular toxicology of combustion-derived nanoparticles (CDNP)
following inhalation exposure. CDNP originate from a number of sources and in this review we
consider diesel soot, welding fume, carbon black and coal fly ash. A substantial literature
demonstrates that these pose a hazard to the lungs through their potential to cause oxidative
stress, inflammation and cancer; they also have the potential to redistribute to other organs
following pulmonary deposition. These different CDNP show considerable heterogeneity in
composition and solubility, meaning that oxidative stress may originate from different components
depending on the particle under consideration. Key CDNP-associated properties of large surface
area and the presence of metals and organics all have the potential to produce oxidative stress.
CDNP may also exert genotoxic effects, depending on their composition. CDNP and their
components also have the potential to translocate to the brain and also the blood, and thereby
reach other targets such as the cardiovascular system, spleen and liver. CDNP therefore can be
seen as a group of particulate toxins unified by a common mechanism of injury and properties of
translocation which have the potential to mediate a range of adverse effects in the lungs and other
organs and warrant further research.
Introduction
Particulate matter (PM) is a complex mixture of different
particle types, much of which are unlikely to cause any
adverse effects and so the hypothesis has arisen that a sub-
component(s) of PM drives the adverse effects. Much
research has been, and is being, undertaken to test various
hypotheses regarding which of the components in fact
drives adverse effects. Combustion has been recognised as
a potential source of harmful particles as well as gaseous
pollutants [1,2]. Epidemiological studies do not readily
allow associations of adverse effects with sub-components
of PM, dependent as they usually are on mass measures of
PM. However several epidemiological studies have been
able to identify combustion-derived particles as an impor-
tant component in driving adverse effects of PM [3-7].
Toxicology can more readily study the components of PM
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onstrating the toxicity of combustion-derived particles
such as diesel soot [8,9], welding fume [10], carbon black
[11] and nanoparticles coal fly-ash [12]. The workplace is
also a site of exposure to combustion-derived nanoparti-
cles as in the case of welding fume and in the manufacture
of carbon black. We focus here on the toxicology of com-
bustion-derived nanoparticles (CDNP) produced in a
range of situations because reports on their mechanisms
of toxicity suggest similarities.
CDNP present a diverse group of materials which gain
commonality because of their origin in combustion proc-
esses and their demonstrated toxicity in various models.
We have attempted to be systematic and have described
the CDNP in terms of their physicochemistry then their
adverse effects and finally their molecular toxicology;
however there are gaps of various sizes in the available
information and so we fall short of a truly systematic
approach. We feel that this review is timely because the
molecular toxicology of these materials is becoming better
understood and the final common pathways of oxidative
stress-mediated inflammation are now considered to
underlie the effects of a range of CDNP. This is outlined in
Figure 1 where the link between oxidative stress and
inflammation is shown. In addition we review the evi-
dence that CDNP and their components can migrate,
from their site of deposition in the lungs, to other target
organs.
Combustion-derived nanoparticles
Nanoparticles are defined as primary particles with at least
one dimension < 100 nm, while ultrafine particles are
defined as particles < 100 nm in all dimensions (W Krey-
ling, personal communication) and are commonly pro-
duced by combustion processes [1,2]. Like other
nanoparticles, CDNP agglomerate readily and move into
the accumulation mode which decreases the particle
number but probably leaves the surface area dose unaf-
fected. NP have the ability to cause inflammation and
also, in the case of insoluble CDNP, have potential to
escape from the site of deposition in the lungs and trans-
locate to the blood and to other target organs [13]. The
exemplar CDNP discussed here (Table 1) include welding
fume and nanoparticulate carbon black, which are both
occupational hazards, coal fly-ash which is an
environmental hazard and diesel soot which is both an
environmental and an occupational hazard. CDNP are
primary in the sense that they arise directly from the com-
bustion process, although their chemistry may change
with aging as the particles undergo chemical interactions
with components of the ambient air pollution cloud. The
process of burning concentrates metals, due to combus-
tion and hence degradation of the organic fraction to a
degree that is dependent on the efficiency of the combus-
tion. At the same time pyrolysis chemistry generates other
complex organic molecules, some of which may persist
along with elemental carbon nanoparticles. Nanoparticles
also form from atmospheric chemistry e.g. sulphate and
nitrate nanoparticles but these will not be discussed here
as they are not derived directly from combustion. The
combustion materials and the mode of combustion will
ultimately determine the characteristics of the CDNP,
including chemical composition, particle size and particle
solubility. The large surface area of CDNP presents maxi-
mal opportunity for dissolution of soluble species from
the surface of the insoluble core. For insoluble NP, the
large surface area provides a surface on which catalytic
chemistry can occur that favours the formation of free rad-
icals. These free radicals are responsible for driving oxida-
tive stress, the underlying mechanism that promotes an
inflammatory response to CDNP. For a range of low tox-
icity, low solubility particle types the surface area alone is
the driver for lung inflammation following instillation in
rats [14]. CDNP may be soluble and release transition
metals or organics as their primary pro-inflammatory
mechanism. Both transition metals and organics can
undergo complex cyclical chemical reactions in the milieu
of the lungs that lead to the production of free radicals
such as superoxide anion or hydroxyl radical [15-17]. By
contrast low toxicity insoluble particles cause inflamma-
tion because of their surfaces; some types of CDNP have
both soluble components and an insoluble core.
As detailed in this review, exposure to CDNP of various
types is associated with a range of adverse health effects
including fibrosis, chronic inflammatory lung disease,
metal fume fever and cancer. These endpoints are found
across a number of exposure conditions and to different
kinds of CDNP but are not unique for CDNP.
This paper examines the evidence for harmful effects of
CDNP and puts these in the context of a unifying hypoth-
esis based on observations that the generic ability of
CDNPs to cause inflammation is via oxidative stress and
activation of redox-sensitive transcription factors that can
lead to the adverse health effects listed below. The ability
of CDNP and their associated metals to translocate to the
blood and the brain are also discussed. These unusual
Figure 1
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can usefully be seen as a group of particulate lung toxins
that act through similar pathways.
Health effects associated with exposure to 
CDNP
CDNP are generated in a number of scenarios including
internal combustion engines, large scale burning of coal
for power generation and in industrial processes where
they often could be produced along with larger particles.
The CDNP considered here are described in Table 1 along
with their salient effects in humans and animals.
Diesel exhaust particulate
Both petrol and diesel fuels undergo combustion in auto-
mobile engines and give rise to CDNP [18,19] but diesel
produces more particles per unit fuel than petrol and is by
far the most-studied of the two regarding adverse health
effects; therefore diesel CDNP are discussed here. Diesel
fuel is a middle distillate of petroleum which contains
paraffins, alkenes and aromatics[20]. On combustion in
automobile engines it produces low solubility carbon-
centred nanoparticles with complex chemical and physi-
cal structure, containing sulphates and an organic fraction
comprising unburnt fuel, lubricating oil and polycyclic
aromatic hydrocarbons along with a range of other chem-
icals, which can condense on the particles [20,21]. Singlet
Diesel nanoparticles are 5–20 nm but readily form com-
plexes chains and aggregates of 60 to 100 nm and larger
[22]. Diesel exhaust particles (DEP) are usually the most
common CDNP in urban environmental air and in envi-
ronmental particulate air pollution (PM10) in conurba-
tions generally; they also occur in an occupational setting.
In the ambient environment the concentration of DEP in
PM10 is likely to range from 5–30 µg/m3 while in occupa-
tional settings levels up to 1000 µg/m3 have been experi-
enced [20]. The adverse health effects of exposure to DEP
have been extensively studied epidemiologically, in ani-
mals and in cells. Epidemiological studies have been
reviewed and show that there is a strong link between
occupational exposure to diesel soot and lung cancer [20].
Animal studies generally support these findings and dem-
onstrate that exposure to DEP and other nanoparticulate
forms of carbon are carcinogenic [23] but these findings
are complicated by the issue of rat lung overload [24]. Rat
lung overload is a condition when very high lung surface
area burden [25] of low toxicity, low soluble particles
leads to failure of clearance, rapid accumulation of dose
with concomitant inflammation and proliferation, which
culminates in fibrosis and cancer. Humans are unlikely to
experience overload levels of diesel soot, even in occupa-
tional settings, and there is a question over whether over-
load can occur at all in humans. It is therefore unlikely
that cancer associated with DEP-exposure in humans
results from mechanism similar to rat lung overload.
Exposure to DEP has also been shown to be highly
inflammatory in rats and mice in non-overload condi-
tions [26-28] and to induce pro inflammatory effects on
cells in vitro [29-31]. The well-documented link between
inflammation and lung cancer [32-34] supports the idea
that diesel exhaust may indeed be carcinogenic via an
inflammatory pathway (see below).
Many studies have demonstrated profound adjuvant
effects of diesel particles on development and intensity of
allergic responses and these effects are mediated by direct
effects of DEP on a wide range of cell types involved in
allergy [35]. These effects could also be mediated indi-
rectly through inflammation and oxidative stress [35]. The
inflammatory effects of DEP appear to be driven by the
particulate component i.e. the surface area effect [23]
although the organic [36] and metal components [37]
also appear to play a role in oxidative and pro-inflamma-
tory effects and thereby affect pathogenicity.
Welding fume
Welding is an industrial technique that involves the join-
ing of metal pieces using a filler metal. The filler metal is
produced from an electrode wire that is consumed during
the welding fusion process. High temperatures are
involved, generating a welding fume as well as radiation,
noise and gases [38] but we focus her on the fume parti-
Table 1: Characteristics of the CDNP considered in this review
CDNP Origin Reported health effects
animals humans
Diesel exhaust particles Combustion of diesel oil Inflammation, fibrosis, cancer, Inflammation, cancer?
Welding fume Welding processes Inflammation; translocation of metals to 
the brain
Metal fume fever, fibrosis, cancer, 
bronchitis
Fly-ash Combustion of coal or oil inflammation no data available
NP Carbon black Combustion of heavy fuel oil Inflammation, lung cancer; translocation of 
particles to the brain
no data availablePage 3 of 14
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welding process oxidises to produce a fume containing
particles of metal oxide such as aluminium, cadmium,
chromium, and copper [38], many of which are water sol-
uble. The exact composition of the welding fume is deter-
mined by the metals involved in the weld and the
composition of the electrode. Welding fume particles are
comprised of a large proportion of nanoparticles [10].
Exposure to welding fume has been associated with both
pulmonary and systemic health endpoints reviewed in
[38]. These include decreases in pulmonary function,
increased airway responsiveness, bronchitis, fibrosis, lung
cancer and increased incidence of respiratory infection; in
addition to these pulmonary effects metal fume fever is
frequently observed in welders [38,39]. This systemic con-
dition is considered to be caused by inhalation of zinc
oxide fumes and it is characterised by acute onset of a flu-
like illness accompanied by a dry cough, dyspnea, muscle
aches, headaches and fever [40]. Metal fume fever is usu-
ally experienced in the first periods of exposure and on
Mondays, with the symptoms declining as the working
week progresses. Welding fume has been studied in both
animals and in cells in culture, and in both it produces
marked pro-inflammatory effects [10,41,42]. These effects
are driven largely by the transition metals [10,42,43]
which undergo redox-cycling resulting in oxidative stress.
Nanoparticulate carbon black
Carbon black (CB) is a low solubility particle produced
industrially from incomplete thermal decomposition of
hydrocarbons [44] in which the process is controlled to
achieve pre-defined and reproducible particle sizes and
properties suitable for a diverse range of industrial appli-
cations. Unlike the other CDNP described here NPCB is
not accidentally produced, and is an industrial product
but it clearly classifies as a CDNP. In thermal-oxidative
processes such as the furnace black process, various types
of hydrocarbon are sprayed into a natural gas-fired fur-
nace and quenched with water to prevent complete burn-
ing [45]. The carbon black particles so-formed are
complex, with a degenerated graphitic crystallite structure
and high power electron micrographs clearly show irregu-
lar layered graphitic plates. [44]. The structure of carbon
black is described as nodules, the roughly spherical pri-
mary structural elements, aggregates which comprise
fused, connected particles and agglomerates, which are
undispersed clusters of aggregates. CB has been studied
extensively as to its toxicology, especially as an example of
a low toxicity, low solubility particle not complicated by
harmful levels of toxicologically-relevant organics or met-
als [23]. In long-term animal studies CB was found to be
a carcinogen although rat lung overload very likely plays
a role in this affect [46].
The smallest nodule-or particle-sized CB comprises pri-
mary particles in the low tens of nanonetres size range. CB
with smallest primary particle sizes produces the highest
optical density (jetness) compared to larger particle sizes,
placing this material in demand for colouring enamels,
acrylics and plastics, as well as inks and paints [44]. This
nanoparticulate CB (NPCB), as it has come to be known,
comprises a portion of the overall CB industry. NPCB was
able to cause detectable but low level pro-inflammatory
effects in rats following 7 hours inhalation exposure [47]
and also following instillation [11] and this appears to be
a consequence of the high surface area area per unit mass
[14]. In cell studies NPCB has been shown to cause oxida-
tive stress, pro-inflammatory gene transcription [48] stim-
ulation of phagocytosis at low doses and inhibition at
higher doses [49]. In studies of the health status of
individuals working in the carbon black industry there is
evidence of abnormalities in chest radiographs and respi-
ratory morbidity, but equivocal findings on lung cancer
[50-52]. However, none of these studies analysed a
worker population exposed solely to NPCB. NPCB has
been used quite extensively in particle toxicology as a
model particle and nanoparticles, so there is a considera-
ble existing database on its toxicity in vitro and in vivo
[53].
Coal fly ash
Pulverised coal combustion is a commonly-used and effi-
cient method of coal burning in power stations. In pulver-
ized coal power stations the pulverised coal is blown into
the furnace and burned off producing a fly ash emission.
This particulate emission is controlled by number or
methodologies including electrostatic precipitators, filters
scrubbers and mechanical collectors [12]. However, these
control measures are not 100% effective and some parti-
cles are released into the environment.
Toxicology studies have in general examined unfraction-
ated pulverised coal fly ash (CFA) and these have shown
generally low toxicity [54], however bioavailable iron has
been reported to underlie an ability to generate oxidative
stress [55,56]. Coal fly ash-exposed rats have been shown
to exhibit increased susceptibility to infection [57], while
a specially-prepared cloud of ultrafine (nanoparticulate)
coal fly ash induced adverse effects on guinea pig lung
function [58]. A recent study systematically examined the
effect of fractionated coal fly ash in pulmonary inflamma-
tion and a nanoparticle fraction was available [12]. This
study showed greatly enhanced potency of the nanopar-
ticulate fraction compared to the fine and coarse fractions,
as seen by enhanced ability to cause lung inflammation
and kill macrophages in culture. The nanoparticle fraction
was not especially enriched for toxic metals and the
increased toxicity of this fraction may be a result of the
high surface area, allowing redox reactions to take place.Page 4 of 14
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inflammatory effects of CDNP in lungs
Based on published studies we hypothesise that CDNP
have their effects through common pathways that pro-
duce inflammation and that oxidative stress is the lead
effect driving the adverse health effects. Table 1 shows the
CDNP studied in this paper along with a description of
their origin and reported health effects in animals and
humans.
There is considerable mechanistic data describing the
molecular events flowing from the deposition in the lungs
of the different CDNP under discussion here and this is
outlined in Figure 2. Figure 2 shows that different compo-
nents of different CDNP can cause oxidative stress that
acts through well-documented redox-sensitive pathways,
such as MAPK and NF-κB, to cause inflammation.
Although the components that mediate these effects differ
greatly between the different CDNP, there is commonality
through their ability to cause oxidative stress and
inflammation.
Diesel exhaust particles
As described above DEP causes inflammation in rat lungs
[28,59] and in human lungs [60] following short-term,
high level exposure. Evidence of the oxidative properties
of DEP in vivo is shown by increased level of 8 OH dG, the
oxidative adduct of hydroxyl radical, in the lungs of rats
following exposure and in cells in culture treated with
DEP [61,62]. DEP causes oxidative stress in a number of
models in vitro such as oxidation of low density lipopro-
tein (LDL) [63] and in exposed epithelial cells [9,64]. The
component responsible for the oxidative stress and subse-
quent pro-inflammatory signaling is principally the
organic fraction [9,30,64,65], although transition metals
may also be involved [37,66]. The organic fraction either
contains, or can be metabolized to, species such as qui-
Figure 2
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gen species [17]
Activation of signaling pathways for pro-inflammatory
gene expression is seen in a number of studies using DEP;
these include MAPK activation [30,67-69] and NF-κB acti-
vation [30,70]. As would be anticipated, activation of
these pathways culminates in transcription of a number of
pro-inflammatory genes such as IL-8 in epithelial cells
treated in vitro [71] and in human lungs exposed by inha-
lation [72]. TNFα has been reported to be increased in
macrophages exposed to DEP in vitro [73] and IL-6 is
released by primed human bronchial epithelial cells
exposed to DEP [74]. Increased expression of the GM-CSF
gene is reported in human epithelial cells exposed to DEP;
in humans exposed to short-term high levels of DEP sim-
ilar to those encountered in a busy garage, bronchial biop-
sies showed increased GROα and RANTES expression in
the bronchial wall [75].
Nanoparticulate Carbon black (NPCB)
As described previously, at high exposures carbon black
causes overload tumours in rats [27,46]. NPCB causes
inflammation and the onset of rat lung overload tumours
at a lower lung mass burden than larger, respirable CB
[76]. This reflects the reliance of rat lung overload on the
particle surface area burden [25], which is much greater
for a given mass of NPCB than the same mass of non-NP
respirable CB. Even at low lung burden NPCB showed evi-
dence of mild pro-inflammatory effects whilst respirable
CB did not [47]. Similar greater inflammogenicity of
NPCB than respirable CB has been described with instilla-
tion models, [11,77].
Reactive oxygen species production has been measured
with NPCB using in vitro cell-free systems [78,79] and oxi-
dative stress has been demonstrated in exposed cells
[48,80]. The chemical basis of the ability of NPCB to cause
oxidative stress [78] is unknown, but unlike highly solu-
ble welding fume, ROS production is not related to metal
or any other soluble component [77]. In a cell free system
the NPCB particles and similarly polystyrene NP, induce
ROS production [81], suggesting that the surface reactivity
is sufficient. However, in cells this ability may also be
related to increased influx of extracellular Ca++ ions seen
with NPCB [82]. Oxidative stress raises intracellular cal-
cium by increasing release of Ca2+ from the endoplasmic
reticulum, by enhancing ingress of Ca2+ through the
plasma membrane calcium channels and through inhibi-
tion of Ca2+ transport out through the ATPase pumps in
the plasma membrane [83]. Oxidative stress caused by
NPCB is translated into activation of NF-κB and IL-8 gene
expression in epithelial cells in vitro [48], while both oxi-
dative stress and calcium are implicated in activation of
AP-1 and TNFα production in macrophages [84]. A recent
study reports that NPCB causes oxidative stress-mediated
proliferation of airway epithelium, involving the Epider-
mal Growth Factor Receptor and the ERK cascade [85].
Welding fume
Exposure to welding fume nanoparticulate in humans is
associated with inflammatory cytokine increases in the
bronchoalveolar lavage (BAL) [86-88] and systemic oxi-
dative stress [43]. The ability of welding fume to generate
free radical is abundantly clear, even in a cell-free environ-
ment with only H2O2 acting as a reductant [42]. Rats
exposed to welding fume show marked pulmonary
inflammatory responses [42,89,90] and lipid peroxida-
tion indicative of oxidative stress [42]. In a comprehensive
study of the molecular signaling pathways leading to
inflammation with welding fume, McNeilly et al demon-
strated that the pro-inflammatory effects of welding fume
in vitro [10] and in vivo [91] were entirely driven by oxida-
tive stress arising from the soluble transition metal com-
ponent. Epithelial cells treated with welding fume or the
soluble transition metals from them showed oxidative
stress leading to MAPK-dependent (manuscript in prepa-
ration) NF-κB and AP-1 activation leading to IL-8 gene
transcription [10]. For welding fume nanoparticles, there-
fore, the soluble transition metals appear to be the pri-
mary mechanism of oxidative stress and inflammation.
Coal fly ash
In the past coal fly ash has been shown to have relatively
low toxicity, for example lower than coal or quartz [54].
Recently there has been increasing interest in the ability of
CFA to release bioavailable iron which can redox cycle to
produce oxidants [55,92]. One study showed that the
ability of a CFA standard to induce IL-8 release from epi-
thelial cells was dependent on size, with the smallest size
fraction (<1 µm) containing the most IL-8-stimulating
activity [92]; this was due to the fact that the bioavailable
iron was concentrated in this fraction. There was no
attempt in this study to collect a nanoparticle fraction. In
a study especially relevant to our review of CDNP, Gil-
mour et al [12] demonstrated that the nanoparticulate
fraction of sub-bituminous coal was much more potent
than any other fraction in causing lung inflammation and
cytotoxicity in vitro, when compared on a mass basis. This
was not obviously linked to enrichment of Fe or any other
toxic metals in the nanoparticulate fraction. Electron
microscopic examination of the nanoparticulate fraction
of coal fly-ashes from bituminous and low-rank coals
showed abundant discrete crystalline particles rich in Fe,
Ti, and Al crystalline phases down to 10 nm in size whilst
low-rank samples contained considerable amounts of
alkaline-earth element aggregates in the form of
phosphates, silicates, and sulfates and mixed species.
Importantly, all coal fly-ash samples exhibited carbona-
ceous particles in the form of soot aggregates with primaryPage 6 of 14
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mixed or coated with multi-element inorganic species
[93]. It seems possible that the soot particles were an
important component in driving the adverse effects in
ways analogous to the effects of diesel soot and NPCB.
There are no further studies on the ability of the NP frac-
tion of CFA to cause oxidative stress or signal for inflam-
matory gene expression but such studies are warranted
and we would predict that, along with the other CDNP
discussed here, the pathway shown in Figure 2 would be
activated, leading to inflammation.
CDNP and the cardiovascular system
Large scale epidemiological studies suggest that inhaled
ambient air pollution particles (PM10) may also have
effects on the cardiovascular system. Small increases in
particulate levels are associated with more cardiovascular
deaths and hospital admissions in both time-series
[94,95] and population studies [96,97]. Cohort studies
have documented an association between elevated partic-
ulate and the onset of acute myocardial infarction [98,99],
an increase in heart rate [100] and a decrease in heart rate
variability [101]. Human chamber studies delivering con-
centrated ambient particles (CAPs) have confirmed that
particulate can have direct effects on cardiovascular phys-
iology with alterations in heart rate variability [101] and
brachial artery diameter [102].
This CAPS work has not been able to discriminate which
size fraction is responsible for any effects but the hypoth-
eses relating to cardiovascular effects of CAPS (and PM in
general) are as follows 1) particle-induced lung inflamma-
tion affects the endothelium, thrombotic potential, fibri-
nolytic balance and atheromatous plaque activity in ways
that favour plaque rupture and thrombosis; 2) particles
enter the interstitium and/or cause inflammation which
affects the autonomic nerve endings that regulate the
heart rhythm leading to dysrhythmia; 3) particles translo-
cate to the blood and have direct effects on the endothe-
lium, plaques and thrombogenic mechanism. In various
models NP are shown to be highly potent in these three
areas of effect i.e. NP are very potent at causing inflamma-
tion, they interstitialise readily and they can gain access to
the blood. For these reasons CDNP, the principal NP in
ambient air, are implicated in the cardiovascular effects of
PM in these CAPS studies.
These studies address the population risks associated with
ambient particulate, but do not allow any assessment of
the contribution of individual air pollutants. In the
Copenhagen Male Study the influence of occupational
exposure on cardiovascular risk was assessed. In these
men, 5 years or more of occupational exposure to welding
fumes doubled the risk of myocardial infarction with
exposure to solder and plastic fumes conferring similar
increases in risk [103].
Figure 3 shows the two predominant mechanistic path-
ways hypothesised to mediate the adverse cardiovascular
effects of CDNP [104,105]. On the right of Figure 3
inflammation caused by the CDNP is seen to affect the
systemic inflammatory response and cause destabilisation
of atheromatous plaques. On the left, bloodborne CDNP
affect endothelial cells, platelets and plaques directly to
enhance thrombogenesis.
CDNP are capable of eliciting an inflammatory response
in the lung which could have stimulatory effects on leuko-
cytes and other cells in the atherosclerotic plaques, lead-
ing to their rupture. This could occur is in the absence of
any transfer of CDNP from the lungs to the circulation as
it might rely on cytokines and other mediators which were
released into the circulation in response to events in the
lungs, affecting events in the plaques. However, CDNP
could also have effects on the cardiovascular system by
virtue of their ability to gain access to the bloodstream.
This has been demonstrated in animal studies for a range
of nanoparticles delivered by inhalation and instillation
[106-111]. Once circulating, CDNP may interact with the
vascular endothelium, or have direct effects on
atherosclerotic plaques by entering them and causing
local oxidative stress and pro-inflammatory effects similar
to those caused in the lungs. Increased inflammation
could destabilise the coronary plaque, resulting in rup-
ture, thrombosis and acute coronary syndrome [104]. Fur-
thermore, particles may interact with circulating
coagulation factors to promote thrombogenesis. There is,
as yet no published data demonstrating that the CDNP
described here gain access to the blood in humans, but the
animal studies suggest that this is a plausible hypothesis.
CDNP and the brain
Recent work by Oberdorster and colleagues has demon-
strated the transfer of radiolabelled nanoparticulate car-
bon from the nose of rats directly into the brain [112]. It
is postulated that this transfer occurs via the olfactory
nerves which run from the roof of the nasal cavity in to the
olfactory lobes of the brain. However, this part of the
brain is well vascularised, providing a potential systemic
portal of deposition. If size is the factor that drives these
effects then there is some concern that CDNP may have
the general property of tropism to the brain. A search of
relevant terms showed no published studies pertaining to
brain transfer of diesel or coal fly-ash. The best-studied of
the CDNP in regard to brain transfer is welding fume. Rats
exposed to stainless steel welding fume over 60 days
showed accumulation of manganese in the blood and
liver but, most importantly, also in various areas of the
brain [113]. Erikson et al [114] showed that inhalationPage 7 of 14
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phosphate produced oxidative stress in the brains of rats
as shown by metallothienin and glutamine synthetase lev-
els; this varied between sexes and with age. In a sub-
chronic exposure study with manganese phosphate there
was accumulation of Mn in the brain but there was no
associated loss of neurons or neurobehavioural effects
[115]. Studies of workers exposed to welding fume, how-
ever, show clear evidence of neurological disease [116]
and Mn is implicated in these effects [117]. It is not
known whether the welding fume particles themselves are
transferred to the brain or only the soluble Mn and other
metals. However, soluble metals are very rapidly lost from
welding fume particles [10] and a soluble salt of Mn was
more efficient than an insoluble Mn salt in gaining access
to the brain following inhalation exposure in rats [118].
Further work is required to improve our understanding of
the factors dictating the transfer of CDNP and their asso-
ciated soluble contaminants to the brain.
CDNP and the liver and spleen
As discussed above, NP of various types are reported to
gain access to the blood. Stuart showed in 1970 that the
liver and the spleen turn black following the instillation of
carbon particle into the blood because the spleen and the
liver have sinusoidal phagocytes which are in contact with
the blood – the 'littoral' macrophages [119]. There is
existing evidence that particles can gain access to the
blood since coalworkers, who receive considerable expo-
sure to particles, show greater numbers of particles in their
Figure 3
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The amount of particulate in the spleen and liver, which
can be assumed to have travelled via the blood, was
greater in coalworkers with more severe lung disease, sug-
gesting that inflamed/damaged lungs may be more sus-
ceptible to egress of particles into the blood than normal
lungs. The normal function of the littoral macrophages of
the spleen and liver is probably to 'sample' for antigens
and xenobiotics in the blood and to quickly remove any
bacteria that gain access to the blood. We may therefore
anticipate that any NP that gain access to the blood will be
taken up by these littoral macrophages in the spleen and
the liver. Particles may also reach hepatocytes and other
spleen cells with consequences that are presently
unknown. However, in line with the above arguments
pertaining to the potential role of NP in the adverse effects
of PM10, we may anticipate that increases in acute phase
proteins during periods of high PM [121] could be due to
direct particle effects on the liver, the primary source of
acute phase proteins [122]. In the single study that has so
far been published concerning the effects of bloodborne
NP on liver function of healthy mice, CDNPs induce
platelet accumulation in the hepatic microvasculature
that was associated with pro-thrombotic changes on the
endothelial surface of hepatic microvessels. [123]. The
accumulation of particles in the liver exerted a strong pro-
coagulatory effect but did not trigger an inflammatory
reaction. The effects of a particle burden on the spleen are
unknown but could include adjuvant effects as observed
with diesel particles and antigens in the lung [124].
CDNP and genotoxicity
The genotoxic properties of various particle types has been
the focus of several studies concerned with elucidating the
role such properties play in particle-associated patho-
genicity [34]. However, the mechanisms involved in par-
ticle-induced genotoxicity remain poorly understood as
particles are uniquely complex compared with soluble
genotoxic/carcinogenic compounds, due to their physical
and chemical characteristics [125]. There is evidence that
3 of the 4 CDNP studied in this review (diesel, NPCB and
welding fume) are carcinogenic in humans or rats
[20,38,126,127]. As mentioned earlier, DEP consist of a
carbon core with adsorbed PAHs, quinones and transition
metals. Genotoxicity, may therefore be caused by the
direct (primary) interaction of PAHs which are known to
cause DNA adduct formation [128] or alternatively via
DNA strand breakage due to the production of reactive
oxygen species generated by associated transition metals
[8]. Carbon black particles are generally almost free of
adsorbed organic compounds; however they have been
shown to produce lung tumours in rats following chronic
inhalation and instillation studies [127,129]. This indi-
rect (secondary) genotoxicity pathway involves the phe-
nomenon of lung particle overload resulting in a chronic
inflammation and hence excessive ROS production lead-
ing to DNA damage. Studies by Knaapen et al, have dem-
onstrated that co-incubation of rat lung epithelial cells
with activated neutrophils in vitro stimulate the formation
of the oxidative DNA lesion 8-OH-dG [32]. Less research
has been carried out on the genotoxic effects of welding
fumes. Some of the major components of welding fumes
include iron, manganese, chromium and in particular
hexavalent chromium (CrVI) chromium which has been
shown to increase levels of 8-OH-dG in rats after inhala-
tion exposure [130]. Yu and co-workers showed that rats
exposed for 30 days to manual metal arc stainless steel
(MMA-SS) welding fumes, exhibited increased DNA dam-
age as measured by the comet assay and immunohisto-
chemistry for 8-OH-dG [131]. Studies investigating the
genotoxic capacity of coal fly ash have shown a role for
particulate size and iron release leading to radical genera-
tion and oxidative DNA damage [132,133] as well as
increased sister-chromatid exchange (SCE) frequencies in
peripheral blood lymphocytes from workers occupation-
ally exposed to coal fly ash [134].
Figure 4Page 9 of 14
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Combustion is considered a source of toxic chemicals and
particles [1] and this review has focused solely on the tox-
icology of the particulate component. Emanating, as they
do, from very diverse combustion scenarios, CDNP have
received variable and piecemeal research attention. This
review has used diesel soot, welding fume, carbon black
and fly-ash as exemplar CDNP to demonstrate that differ-
ent CDNP in fact have many properties in common that
suggest that they can be viewed as a coherent class of par-
ticulate toxins. They are unified by their combustion ori-
gin, small size, universal mechanism of injury and
common properties of translocation which have the
potential to mediate a range of adverse effects in the lungs
and other organs. Notably, the CDNP studied here all
have the potential to cause oxidative stress as an integral
part of their pathogenic mechanism. This oxidative stress
can cause inflammation and its local and systemic acute
and chronic sequelae, as well as causing oxidative adducts
in epithelium that can contribute to carcinogenesis.
CDNP originating from any source can therefore be con-
sidered a potential hazard to the lungs and other systems
through the pathways of oxidative stress, inflammation
and carcinogenesis. This is summarised in Figure 4 where
the link between oxidative stress and inflammation-
related effects are shown along with carcinogenic effects of
oxidative stress.
Of course the temperature, conditions and substrate for
combustion mean that there is considerable heterogeneity
in composition between, for example, welding fume and
diesel soot. Therefore the key oxidative stress event may
originate from different components depending on the
particle under consideration. Components that may cause
oxidative stress include CDNP-associated surfaces, metals
or organics; this oxidative stress then acts through oxida-
tive stress-responsive signalling pathways to affect
responses such as inflammation and proliferation. In
addition, oxidative stress can also cause oxidative genoto-
xic DNA adducts such as 8-OH-dG whilst bulky PAH-
derived adducts may also form. Both adduct types can
lead to mutation. Different components of CDNP may
interact to enhance the level of oxidative stress, as in the
case of metals and organics interacting in the redox-
cycling of quinoid organics [17] or CDNP surfaces and
transition metals interacting additively in their ability to
cause inflammation [81].
In addition to the local inflammatory effects of CDNP at
their sites of deposition they have the potential to translo-
cate away from their site of deposition to the blood and
brain. Bloodborne particles will be delivered to the cardi-
ovascular system, spleen and liver. The cardiovascular sys-
tem has emerged as a target for the effects of PM10 [104,
135] and it is likely that the CDNP in PM in fact mediate
this effect [3-6]. They may do this through causing inflam-
mation in the lungs which then impacts on inflammatory
processes in the atheromatous plaques that govern their
stability and development. Inflammation in the lungs
may also affect the thrombotic potential of the blood.
Alternatively, direct effects of bloodborne particles on the
endothelium, clotting system and on atheromatous
plaques could be responsible. Bloodborne CDNP may
deposit in the spleen, liver and heart and in these situa-
tions they may have numerous additional adverse effects.
Combustion is a ubiquitous in the modern world and the
generation of CDNP is correspondingly omnipresent.
Much research emphasis has been placed on traffic-
derived CDNP in PM and rightly so as they are the source
of most CDNP in our cities where the greatest potential
for human exposure exists. However it is also clear that
there is considerable potential for mixed exposures to
occur in specific scenarios, e.g. a welder working in a busy
street. The interactions between different particle types are
unknown but the common pathway of oxidative stress
means that there is potential for additive or synergistic
effects. Furthermore the involvement of oxidative stress in
a number of chronic diseases such as asthma, COPD and
coronary artery disease argues a powerful case for exist-
ence of susceptible populations, already well-studied in
the adverse effects of PM.
CDNP represent an interesting and ubiquitous category of
pathogenic particles whose adverse effects are substantial
and additions to the list of candidate CDNP are to be
anticipated. More research is warranted into the effects of
CDNP at numerous levels from factors dictating their
translocation between organs and tissue to their effect in
sub-cellular signalling. Viewing CDNP as a class of parti-
cles with common origins and a strong hypothesis-based
understanding of their toxic mechanisms should provide
impetus and direction to research on existing and new
CDNP, leading to a greater understanding.
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